NASDAQ:NAGE | Free Cash Flow | Niagen Bioscience, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-01-01 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.19M
2025-12-31$679,000.00
2025-03-31$7.88M
2024-12-31$8.58M
2024-03-31$295,000.00
2023-12-31$649,000.00
2023-03-31$2.79M
2022-12-31-$328,000.00
2022-03-31-$7.2M
2021-12-31-$4.94M
2021-03-31-$5.41M
2020-12-31$22,000.00
2020-03-31-$5.22M$15,000.00-$5.24M
2019-12-31-$610,000.00$280,000.00-$890,000.00
2019-03-31-$3.05M$239,000.00-$3.29M
2018-12-31-$5.14M$10,000.00-$5.15M
2018-03-31-$3.99M$161,000.00-$4.15M
2017-12-30-$3.77M$295,000.00-$4.06M
2017-04-01-$51,000.00$162,000.00-$213,000.00
2016-12-31$191,186.00$563,944.00-$372,758.00
2016-04-02-$2.9M$16,629.00-$2.91M-1139.44%
2016-01-02-$853,576.00$282,466.00-$1.14M
2015-04-04-$591,058.00$95,778.00-$686,836.00
2015-01-03-$245,738.00$69,668.00-$315,406.00
2014-03-29-$1.4M$14,623.00-$1.42M
2013-12-28-$1.73M$19,826.00-$1.75M
2013-03-30-$705,802.00$7,428.00-$713,230.00
2012-12-29-$749,842.00$10,791.00-$760,633.00
2012-03-31-$4.66M$4,714.00-$4.66M
2011-12-31-$1.6M$24,294.00-$1.63M
2011-04-02$247,290.00$58,693.00$188,597.00
2011-01-01-$846,809.00$44,377.00-$891,186.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$13.5M
2024-12-31$12.11M
2023-12-31$7.12M
2022-12-31-$15.1M
2021-12-31-$24.16M
2020-12-31-$10.6M
2019-12-31-$20.44M$743,000.00-$21.18M
2018-12-31-$20.91M$1.32M-$22.23M
2017-12-30-$9.8M$1.17M-$10.97M
2016-12-31-$2.94M$1.5M-$4.44M
2016-01-02-$2.11M$525,231.00-$2.64M
2015-01-03-$2.58M$123,096.00-$2.7M
2013-12-28-$3.91M$137,349.00-$4.04M
2012-12-29-$10.12M$24,555.00-$10.14M
2011-12-31-$4.1M$150,663.00-$4.25M
2011-01-01-$2.66M$169,136.00-$2.83M